Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of 370.41 billion as of November 13, 2025. Its market cap has decreased by -35.28% in one year.

Market Cap

370.41B

Enterprise Value

285.55B

Revenue

75.93B

Ranking

n/a

PE Ratio

15.18

Stock Price

60.66

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 177.17M to 370.41B, an increase of 208,974.97%. That is a compound annual growth rate of 25.78%.

Market Cap History

Date	Market Cap	% Change
Nov 12, 2025	370.41B	-21.86%
Dec 31, 2024	474.01B	4.59%
Dec 29, 2023	453.22B	11.26%
Dec 30, 2022	407.37B	10.73%
Dec 31, 2021	367.89B	38.93%
Dec 31, 2020	264.80B	60.49%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Rede D'Or São Luiz	101.14B
Raia Drogasil	39.23B
Hypera	16.31B
Fleury	8.62B
Odontoprev	6.72B
Empreendimentos Pague Menos	2.94B
Diagnósticos da América	2.56B
Blau Farmacêutica	2.26B

Market Cap Rankings